Randomised trial of nadolol alone or with isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis
- 1 December 1996
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 348 (9043) , 1677-1681
- https://doi.org/10.1016/s0140-6736(96)05406-2
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosisPublished by Elsevier ,1995
- The treatment of portal hypertension: A meta-analytic reviewHepatology, 1995
- Propranolol compared with propranolol plus isosorbide dinitrate in portal-hypertensive patients: Long-term hemodynamic and renal effectsHepatology, 1993
- Prevention of First Bleeding in CirrhosisAnnals of Internal Medicine, 1992
- Beta-Adrenergic–Antagonist Drugs in the Prevention of Gastrointestinal Bleeding in Patients with Cirrhosis and Esophageal VaricesNew England Journal of Medicine, 1991
- Propranolol Compared with Propranolol plus Isosorbide-5-Mononitrate for Portal Hypertension in CirrhosisAnnals of Internal Medicine, 1991
- Importance of the 1-month-effect of nadolol on portal pressure in predicting failure of prevention of rebleeding in cirrhosisJournal of Hepatology, 1991
- Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhageGastroenterology, 1990
- Enhancement of Portal Pressure Reduction by the Association of Isosorbide–5–Mononitrate to Propranolol Administration in Patients With CirrhosisHepatology, 1990
- Prediction of variceal hemorrhage by esophageal endoscopyGastrointestinal Endoscopy, 1981